Public Transparency Statement

Royal Liver Building Medical Group is committed to delivering safe, ethical, effective, clinically approved patient-centred healthcare across all of its specialist medical services.

Every consultation, and treatment provided within the Group is guided by clinical evidence, ethical boundaries, professional judgement and the individualised needs of each patient. Regardless of speciality, treatment should only proceed where it is clinically appropriate, safe and in the patient's best interests.

Our clinicians reserve the right to decline or postpone treatment if they believe that proceeding would not support the patient's health, wellbeing or safety.

Where additional arrangements may be required to support the patient’s safety these will be discussed with the patient and bespoke plans of care may be developed.

“This policy underpins our commitment to transparency, accountability, and the delivery of patient-centred, clinically safe and effective care, aligned with national standards and the expectations of regulatory and professional bodies across the Royal Liver Building Medical Group.”

The Royal Liver Building Medical Group is committed to safeguarding every patient who receives care within our clinics.

“Treatment may be postponed or declined if there are concerns about a patient’s capacity to make informed decisions, indicators of vulnerability, safeguarding requirements, or any circumstance that could place the patient at avoidable or unnecessary risk.”

Where appropriate, clinicians may recommend additional assessments, or referral to another healthcare professional as part of your plan of care.

Treatment may be declined or postponed where a patient's medical history, current health or clinical condition increases the risks associated with a proposed procedure or intervention.

This may include, but is not limited to:

• Uncontrolled/unstable medical conditions e.g. Diabetes,
• Significant cardiovascular disease
• Active infection
• Medication risks such as the of anticoagulants, anti-platelet or other medications following medical review and assessment
• Complex systemic disease
• Acute illness or unresolved diagnostic concerns

Where appropriate, clinicians may request information from the patient's General Practitioner (GP) or treating specialist before making a final decision regarding suitability for treatment.

Patient wellbeing extends beyond physical health.

Where clinicians identify that emotional wellbeing, psychological vulnerability, or unrealistic expectations may compromise clinical outcomes, treatment may be postponed or declined until it is deemed appropriate and safe to proceed.”

Patients may be encouraged to seek further support or additional medical advice where this is considered beneficial.

The patient remains at the centre of informed decision making and will be provided with clear information relating to the proposed treatment/s taking into account the benefits, expected outcome, risks supporting the patient to make a fully informed decision which meets their needs and expectations.

“Clinicians may decline treatment when they believe a patient:

• Does not fully understand the risks, benefits, or implications of the proposed treatment
• Appears uncertain or hesitant about proceeding with the planned treatment
• Feels pressured or influenced in their decision-making
• Is unlikely to benefit from the requested treatment

“Declining treatment is not a refusal of care. It is a core professional responsibility, ensuring that investigations or interventions are only undertaken when they are clinically safe, appropriate, and genuinely in the patient’s best interests. Clinicians must balance the patient’s desired outcomes with realistic expectations, prioritising welfare, safety, and ethical practice at all times. Patient wellbeing will always take precedence over any commercial considerations.”

Where there is uncertainty regarding a patient’s suitability for the treatment they have requested, the case may be reviewed through the Medical Group’s governance framework. This process involves senior clinicians, clinical governance representatives, and, where appropriate, the senior leadership team, to determine an agreed clinical position on whether it is appropriate and safe to proceed with treatment.

“This process ensures that complex clinical decisions are made in a structured, accountable, and transparent manner, with patient safety and optimal outcomes as the overriding priority.”

This approach aligns with professional and regulatory standards including:

• Health and Social Care Act 2008 Regulated Activities Regulations
• Regulation 10 – Dignity and Respect
• Regulation 12 – Safe Care and Treatment
• Regulation 17 – Good Governance
• General Medical Council (GMC) Good Medical Practice

Relevant professional standards applicable to each medical speciality delivered within Royal Liver Building Medical Group.